Phreesia, Inc. (NYSE:PHR) SVP David Linetsky Sells 2,011 Shares of Stock

Phreesia, Inc. (NYSE:PHR) SVP David Linetsky sold 2,011 shares of the stock in a transaction on Tuesday, October 15th. The shares were sold at an average price of $21.03, for a total transaction of $42,291.33. Following the transaction, the senior vice president now directly owns 201,307 shares in the company, valued at approximately $4,233,486.21. This represents a 0.00 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link.

David Linetsky also recently made the following trade(s):

• On Thursday, September 19th, David Linetsky sold 24 shares of Phreesia stock. The shares were sold at an average price of $24.04, for a total transaction of $576.96.
• On Tuesday, September 17th, David Linetsky sold 36 shares of Phreesia stock. The stock was sold at an average price of $24.77, for a total value of $891.72.
• On Tuesday, September 10th, David Linetsky sold 1,716 shares of Phreesia stock. The stock was sold at an average price of $23.25, for a total value of $39,897.00.

Phreesia Stock Performance

Phreesia stock opened at $20.40 on Friday. Phreesia, Inc. has a twelve month low of $12.05 and a twelve month high of $29.16. The company has a quick ratio of 1.77, a current ratio of 1.77 and a debt-to-equity ratio of 0.03. The company has a market capitalization of $1.17 billion, a P/E ratio of -9.40 and a beta of 0.93. The stock’s 50 day moving average is $23.36 and its 200 day moving average is $22.44.

Phreesia (NYSE:PHR) last released its earnings results on Wednesday, September 4th. The company reported ($0.31) EPS for the quarter, topping analysts’ consensus estimates of ($0.37) by $0.06. The firm had revenue of $102.12 million for the quarter, compared to analysts’ expectations of $101.76 million. Phreesia had a negative return on equity of 39.34% and a negative net margin of 25.73%. On average, equities research analysts predict that Phreesia, Inc. will post -1.23 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

PHR has been the subject of a number of recent analyst reports. Robert W. Baird upped their price target on shares of Phreesia from $31.00 to $34.00 and gave the company an “outperform” rating in a report on Friday, September 6th. Royal Bank of Canada reaffirmed a “sector perform” rating and set a $23.00 price objective on shares of Phreesia in a research note on Friday, September 27th. Needham & Company LLC restated a “buy” rating and set a $29.00 price target on shares of Phreesia in a report on Thursday, September 5th. JMP Securities reiterated a “market outperform” rating and issued a $30.00 price objective on shares of Phreesia in a report on Thursday, September 5th. Finally, DA Davidson reissued a “buy” rating and set a $32.00 target price on shares of Phreesia in a research note on Thursday, September 5th. One analyst has rated the stock with a hold rating and eleven have issued a buy rating to the company. Based on data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $29.42.

Institutional Inflows and Outflows

Several large investors have recently bought and sold shares of the company. Capital International Investors grew its holdings in shares of Phreesia by 221.1% during the first quarter. Capital International Investors now owns 2,593,063 shares of the company’s stock valued at $62,052,000 after buying an additional 1,785,463 shares during the last quarter. Champlain Investment Partners LLC bought a new position in shares of Phreesia during the first quarter valued at $29,941,000. Blair William & Co. IL lifted its holdings in shares of Phreesia by 42.6% during the first quarter. Blair William & Co. IL now owns 752,700 shares of the company’s stock valued at $18,012,000 after purchasing an additional 224,950 shares in the last quarter. Vanguard Group Inc. boosted its position in shares of Phreesia by 4.4% during the fourth quarter. Vanguard Group Inc. now owns 4,628,441 shares of the company’s stock valued at $107,148,000 after buying an additional 194,035 shares during the last quarter. Finally, Deerfield Management Company L.P. Series C purchased a new position in Phreesia in the 2nd quarter worth about $4,078,000. 92.10% of the stock is owned by hedge funds and other institutional investors.

About Phreesia

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.